NOS2 and neoplasm: Besides the suppression of the anti-tumor activity of T and NK cells by means of arginase 1 and inducible nitric oxide synthase (iNoS) (151–153), MDSCs can foster tumor growth by releasing MMPs that increase the bioavailability of VEGF within the tumor microenvironment (136, 147).